カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

血漿由来第VIII因子の世界市場2022：200IU、250IU

■ 英語タイトル：Global Plasma-derived Factor VIII Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22DC3895）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22DC3895
■ 発行日：2023年1月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：94
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[血漿由来第VIII因子の世界市場2022：200IU、250IU]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

世界の血漿由来第VIII因子市場レポートは、グローバル市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
Global Info Research社の最新のリサーチによると、世界の血漿由来第VIII因子の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

血漿由来第VIII因子市場はタイプとアプリケーションによって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメントは次をカバーします。
・200IU、250IU

アプリケーション別セグメントは次のように区分されます。
・病院、薬局

世界の血漿由来第VIII因子市場の主要な市場プレーヤーは以下のとおりです。
・Takeda、Octapharma、CSL、Grifols、Greencross、Kedrion、BPL、Hualan Bio、RAAS

地域別セグメントは次の地域・国をカバーします。
・北米（アメリカ、カナダ、メキシコ）
・欧州（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南米（ブラジル、アルゼンチン、コロンビア）
・中東/アフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査資料の内容は計15章あります。
・第1章では、血漿由来第VIII因子製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な血漿由来第VIII因子メーカーの企業概要、2019年～2022年までの血漿由来第VIII因子の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な血漿由来第VIII因子メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別血漿由来第VIII因子の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの血漿由来第VIII因子の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での血漿由来第VIII因子市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および血漿由来第VIII因子の産業チェーンを掲載しています。
・第13、14、15章では、血漿由来第VIII因子の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
– 血漿由来第VIII因子の概要
– 種類別分析（2017年vs2021年vs2028年）：200IU、250IU
– 用途別分析（2017年vs2021年vs2028年）：病院、薬局
– 世界の血漿由来第VIII因子市場規模・予測
– 世界の血漿由来第VIII因子生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Takeda、Octapharma、CSL、Grifols、Greencross、Kedrion、BPL、Hualan Bio、RAAS
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：200IU、250IU
・用途別分析2017年-2028年：病院、薬局
・血漿由来第VIII因子の北米市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・血漿由来第VIII因子のヨーロッパ市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・血漿由来第VIII因子のアジア市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・血漿由来第VIII因子の南米市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・血漿由来第VIII因子の中東・アフリカ市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Plasma-derived Factor VIII Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Plasma-derived Factor VIII Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 200IU
1.2.3 250IU
1.3 Market Analysis by Application
1.3.1 Overview: Global Plasma-derived Factor VIII Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Global Plasma-derived Factor VIII Market Size & Forecast
1.4.1 Global Plasma-derived Factor VIII Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Plasma-derived Factor VIII Sales in Volume (2017-2028)
1.4.3 Global Plasma-derived Factor VIII Price (2017-2028)
1.5 Global Plasma-derived Factor VIII Production Capacity Analysis
1.5.1 Global Plasma-derived Factor VIII Total Production Capacity (2017-2028)
1.5.2 Global Plasma-derived Factor VIII Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Plasma-derived Factor VIII Market Drivers
1.6.2 Plasma-derived Factor VIII Market Restraints
1.6.3 Plasma-derived Factor VIII Trends Analysis
2 Manufacturers Profiles
2.1 Takeda
2.1.1 Takeda Details
2.1.2 Takeda Major Business
2.1.3 Takeda Plasma-derived Factor VIII Product and Services
2.1.4 Takeda Plasma-derived Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Octapharma
2.2.1 Octapharma Details
2.2.2 Octapharma Major Business
2.2.3 Octapharma Plasma-derived Factor VIII Product and Services
2.2.4 Octapharma Plasma-derived Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 CSL
2.3.1 CSL Details
2.3.2 CSL Major Business
2.3.3 CSL Plasma-derived Factor VIII Product and Services
2.3.4 CSL Plasma-derived Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Grifols
2.4.1 Grifols Details
2.4.2 Grifols Major Business
2.4.3 Grifols Plasma-derived Factor VIII Product and Services
2.4.4 Grifols Plasma-derived Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Greencross
2.5.1 Greencross Details
2.5.2 Greencross Major Business
2.5.3 Greencross Plasma-derived Factor VIII Product and Services
2.5.4 Greencross Plasma-derived Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Kedrion
2.6.1 Kedrion Details
2.6.2 Kedrion Major Business
2.6.3 Kedrion Plasma-derived Factor VIII Product and Services
2.6.4 Kedrion Plasma-derived Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 BPL
2.7.1 BPL Details
2.7.2 BPL Major Business
2.7.3 BPL Plasma-derived Factor VIII Product and Services
2.7.4 BPL Plasma-derived Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Hualan Bio
2.8.1 Hualan Bio Details
2.8.2 Hualan Bio Major Business
2.8.3 Hualan Bio Plasma-derived Factor VIII Product and Services
2.8.4 Hualan Bio Plasma-derived Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 RAAS
2.9.1 RAAS Details
2.9.2 RAAS Major Business
2.9.3 RAAS Plasma-derived Factor VIII Product and Services
2.9.4 RAAS Plasma-derived Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Plasma-derived Factor VIII Breakdown Data by Manufacturer
3.1 Global Plasma-derived Factor VIII Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Plasma-derived Factor VIII Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Plasma-derived Factor VIII
3.4 Market Concentration Rate
3.4.1 Top 3 Plasma-derived Factor VIII Manufacturer Market Share in 2021
3.4.2 Top 6 Plasma-derived Factor VIII Manufacturer Market Share in 2021
3.5 Global Plasma-derived Factor VIII Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Plasma-derived Factor VIII Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Plasma-derived Factor VIII Market Size by Region
4.1.1 Global Plasma-derived Factor VIII Sales in Volume by Region (2017-2028)
4.1.2 Global Plasma-derived Factor VIII Revenue by Region (2017-2028)
4.2 North America Plasma-derived Factor VIII Revenue (2017-2028)
4.3 Europe Plasma-derived Factor VIII Revenue (2017-2028)
4.4 Asia-Pacific Plasma-derived Factor VIII Revenue (2017-2028)
4.5 South America Plasma-derived Factor VIII Revenue (2017-2028)
4.6 Middle East and Africa Plasma-derived Factor VIII Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Plasma-derived Factor VIII Sales in Volume by Type (2017-2028)
5.2 Global Plasma-derived Factor VIII Revenue by Type (2017-2028)
5.3 Global Plasma-derived Factor VIII Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Plasma-derived Factor VIII Sales in Volume by Application (2017-2028)
6.2 Global Plasma-derived Factor VIII Revenue by Application (2017-2028)
6.3 Global Plasma-derived Factor VIII Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Plasma-derived Factor VIII Sales by Type (2017-2028)
7.2 North America Plasma-derived Factor VIII Sales by Application (2017-2028)
7.3 North America Plasma-derived Factor VIII Market Size by Country
7.3.1 North America Plasma-derived Factor VIII Sales in Volume by Country (2017-2028)
7.3.2 North America Plasma-derived Factor VIII Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Plasma-derived Factor VIII Sales by Type (2017-2028)
8.2 Europe Plasma-derived Factor VIII Sales by Application (2017-2028)
8.3 Europe Plasma-derived Factor VIII Market Size by Country
8.3.1 Europe Plasma-derived Factor VIII Sales in Volume by Country (2017-2028)
8.3.2 Europe Plasma-derived Factor VIII Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Plasma-derived Factor VIII Sales by Type (2017-2028)
9.2 Asia-Pacific Plasma-derived Factor VIII Sales by Application (2017-2028)
9.3 Asia-Pacific Plasma-derived Factor VIII Market Size by Region
9.3.1 Asia-Pacific Plasma-derived Factor VIII Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Plasma-derived Factor VIII Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Plasma-derived Factor VIII Sales by Type (2017-2028)
10.2 South America Plasma-derived Factor VIII Sales by Application (2017-2028)
10.3 South America Plasma-derived Factor VIII Market Size by Country
10.3.1 South America Plasma-derived Factor VIII Sales in Volume by Country (2017-2028)
10.3.2 South America Plasma-derived Factor VIII Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Plasma-derived Factor VIII Sales by Type (2017-2028)
11.2 Middle East & Africa Plasma-derived Factor VIII Sales by Application (2017-2028)
11.3 Middle East & Africa Plasma-derived Factor VIII Market Size by Country
11.3.1 Middle East & Africa Plasma-derived Factor VIII Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Plasma-derived Factor VIII Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Plasma-derived Factor VIII and Key Manufacturers
12.2 Manufacturing Costs Percentage of Plasma-derived Factor VIII
12.3 Plasma-derived Factor VIII Production Process
12.4 Plasma-derived Factor VIII Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Plasma-derived Factor VIII Typical Distributors
13.3 Plasma-derived Factor VIII Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Plasma-derived Factor VIII Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Plasma-derived Factor VIII Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Takeda Basic Information, Manufacturing Base and Competitors
Table 4. Takeda Major Business
Table 5. Takeda Plasma-derived Factor VIII Product and Services
Table 6. Takeda Plasma-derived Factor VIII Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Octapharma Basic Information, Manufacturing Base and Competitors
Table 8. Octapharma Major Business
Table 9. Octapharma Plasma-derived Factor VIII Product and Services
Table 10. Octapharma Plasma-derived Factor VIII Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. CSL Basic Information, Manufacturing Base and Competitors
Table 12. CSL Major Business
Table 13. CSL Plasma-derived Factor VIII Product and Services
Table 14. CSL Plasma-derived Factor VIII Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Grifols Basic Information, Manufacturing Base and Competitors
Table 16. Grifols Major Business
Table 17. Grifols Plasma-derived Factor VIII Product and Services
Table 18. Grifols Plasma-derived Factor VIII Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Greencross Basic Information, Manufacturing Base and Competitors
Table 20. Greencross Major Business
Table 21. Greencross Plasma-derived Factor VIII Product and Services
Table 22. Greencross Plasma-derived Factor VIII Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Kedrion Basic Information, Manufacturing Base and Competitors
Table 24. Kedrion Major Business
Table 25. Kedrion Plasma-derived Factor VIII Product and Services
Table 26. Kedrion Plasma-derived Factor VIII Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. BPL Basic Information, Manufacturing Base and Competitors
Table 28. BPL Major Business
Table 29. BPL Plasma-derived Factor VIII Product and Services
Table 30. BPL Plasma-derived Factor VIII Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 32. Hualan Bio Major Business
Table 33. Hualan Bio Plasma-derived Factor VIII Product and Services
Table 34. Hualan Bio Plasma-derived Factor VIII Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. RAAS Basic Information, Manufacturing Base and Competitors
Table 36. RAAS Major Business
Table 37. RAAS Plasma-derived Factor VIII Product and Services
Table 38. RAAS Plasma-derived Factor VIII Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Global Plasma-derived Factor VIII Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 40. Global Plasma-derived Factor VIII Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 41. Market Position of Manufacturers in Plasma-derived Factor VIII, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 42. Global Plasma-derived Factor VIII Production Capacity by Company, (K Units): 2020 VS 2021
Table 43. Head Office and Plasma-derived Factor VIII Production Site of Key Manufacturer
Table 44. Plasma-derived Factor VIII New Entrant and Capacity Expansion Plans
Table 45. Plasma-derived Factor VIII Mergers & Acquisitions in the Past Five Years
Table 46. Global Plasma-derived Factor VIII Sales by Region (2017-2022) & (K Units)
Table 47. Global Plasma-derived Factor VIII Sales by Region (2023-2028) & (K Units)
Table 48. Global Plasma-derived Factor VIII Revenue by Region (2017-2022) & (USD Million)
Table 49. Global Plasma-derived Factor VIII Revenue by Region (2023-2028) & (USD Million)
Table 50. Global Plasma-derived Factor VIII Sales by Type (2017-2022) & (K Units)
Table 51. Global Plasma-derived Factor VIII Sales by Type (2023-2028) & (K Units)
Table 52. Global Plasma-derived Factor VIII Revenue by Type (2017-2022) & (USD Million)
Table 53. Global Plasma-derived Factor VIII Revenue by Type (2023-2028) & (USD Million)
Table 54. Global Plasma-derived Factor VIII Price by Type (2017-2022) & (USD/Unit)
Table 55. Global Plasma-derived Factor VIII Price by Type (2023-2028) & (USD/Unit)
Table 56. Global Plasma-derived Factor VIII Sales by Application (2017-2022) & (K Units)
Table 57. Global Plasma-derived Factor VIII Sales by Application (2023-2028) & (K Units)
Table 58. Global Plasma-derived Factor VIII Revenue by Application (2017-2022) & (USD Million)
Table 59. Global Plasma-derived Factor VIII Revenue by Application (2023-2028) & (USD Million)
Table 60. Global Plasma-derived Factor VIII Price by Application (2017-2022) & (USD/Unit)
Table 61. Global Plasma-derived Factor VIII Price by Application (2023-2028) & (USD/Unit)
Table 62. North America Plasma-derived Factor VIII Sales by Country (2017-2022) & (K Units)
Table 63. North America Plasma-derived Factor VIII Sales by Country (2023-2028) & (K Units)
Table 64. North America Plasma-derived Factor VIII Revenue by Country (2017-2022) & (USD Million)
Table 65. North America Plasma-derived Factor VIII Revenue by Country (2023-2028) & (USD Million)
Table 66. North America Plasma-derived Factor VIII Sales by Type (2017-2022) & (K Units)
Table 67. North America Plasma-derived Factor VIII Sales by Type (2023-2028) & (K Units)
Table 68. North America Plasma-derived Factor VIII Sales by Application (2017-2022) & (K Units)
Table 69. North America Plasma-derived Factor VIII Sales by Application (2023-2028) & (K Units)
Table 70. Europe Plasma-derived Factor VIII Sales by Country (2017-2022) & (K Units)
Table 71. Europe Plasma-derived Factor VIII Sales by Country (2023-2028) & (K Units)
Table 72. Europe Plasma-derived Factor VIII Revenue by Country (2017-2022) & (USD Million)
Table 73. Europe Plasma-derived Factor VIII Revenue by Country (2023-2028) & (USD Million)
Table 74. Europe Plasma-derived Factor VIII Sales by Type (2017-2022) & (K Units)
Table 75. Europe Plasma-derived Factor VIII Sales by Type (2023-2028) & (K Units)
Table 76. Europe Plasma-derived Factor VIII Sales by Application (2017-2022) & (K Units)
Table 77. Europe Plasma-derived Factor VIII Sales by Application (2023-2028) & (K Units)
Table 78. Asia-Pacific Plasma-derived Factor VIII Sales by Region (2017-2022) & (K Units)
Table 79. Asia-Pacific Plasma-derived Factor VIII Sales by Region (2023-2028) & (K Units)
Table 80. Asia-Pacific Plasma-derived Factor VIII Revenue by Region (2017-2022) & (USD Million)
Table 81. Asia-Pacific Plasma-derived Factor VIII Revenue by Region (2023-2028) & (USD Million)
Table 82. Asia-Pacific Plasma-derived Factor VIII Sales by Type (2017-2022) & (K Units)
Table 83. Asia-Pacific Plasma-derived Factor VIII Sales by Type (2023-2028) & (K Units)
Table 84. Asia-Pacific Plasma-derived Factor VIII Sales by Application (2017-2022) & (K Units)
Table 85. Asia-Pacific Plasma-derived Factor VIII Sales by Application (2023-2028) & (K Units)
Table 86. South America Plasma-derived Factor VIII Sales by Country (2017-2022) & (K Units)
Table 87. South America Plasma-derived Factor VIII Sales by Country (2023-2028) & (K Units)
Table 88. South America Plasma-derived Factor VIII Revenue by Country (2017-2022) & (USD Million)
Table 89. South America Plasma-derived Factor VIII Revenue by Country (2023-2028) & (USD Million)
Table 90. South America Plasma-derived Factor VIII Sales by Type (2017-2022) & (K Units)
Table 91. South America Plasma-derived Factor VIII Sales by Type (2023-2028) & (K Units)
Table 92. South America Plasma-derived Factor VIII Sales by Application (2017-2022) & (K Units)
Table 93. South America Plasma-derived Factor VIII Sales by Application (2023-2028) & (K Units)
Table 94. Middle East & Africa Plasma-derived Factor VIII Sales by Region (2017-2022) & (K Units)
Table 95. Middle East & Africa Plasma-derived Factor VIII Sales by Region (2023-2028) & (K Units)
Table 96. Middle East & Africa Plasma-derived Factor VIII Revenue by Region (2017-2022) & (USD Million)
Table 97. Middle East & Africa Plasma-derived Factor VIII Revenue by Region (2023-2028) & (USD Million)
Table 98. Middle East & Africa Plasma-derived Factor VIII Sales by Type (2017-2022) & (K Units)
Table 99. Middle East & Africa Plasma-derived Factor VIII Sales by Type (2023-2028) & (K Units)
Table 100. Middle East & Africa Plasma-derived Factor VIII Sales by Application (2017-2022) & (K Units)
Table 101. Middle East & Africa Plasma-derived Factor VIII Sales by Application (2023-2028) & (K Units)
Table 102. Plasma-derived Factor VIII Raw Material
Table 103. Key Manufacturers of Plasma-derived Factor VIII Raw Materials
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Plasma-derived Factor VIII Typical Distributors
Table 107. Plasma-derived Factor VIII Typical Customers
List of Figures
Figure 1. Plasma-derived Factor VIII Picture
Figure 2. Global Plasma-derived Factor VIII Revenue Market Share by Type in 2021
Figure 3. 200IU
Figure 4. 250IU
Figure 5. Global Plasma-derived Factor VIII Revenue Market Share by Application in 2021
Figure 6. Hospital
Figure 7. Pharmacy
Figure 8. Global Plasma-derived Factor VIII Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 9. Global Plasma-derived Factor VIII Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Plasma-derived Factor VIII Sales (2017-2028) & (K Units)
Figure 11. Global Plasma-derived Factor VIII Price (2017-2028) & (USD/Unit)
Figure 12. Global Plasma-derived Factor VIII Production Capacity (2017-2028) & (K Units)
Figure 13. Global Plasma-derived Factor VIII Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Plasma-derived Factor VIII Market Drivers
Figure 15. Plasma-derived Factor VIII Market Restraints
Figure 16. Plasma-derived Factor VIII Market Trends
Figure 17. Global Plasma-derived Factor VIII Sales Market Share by Manufacturer in 2021
Figure 18. Global Plasma-derived Factor VIII Revenue Market Share by Manufacturer in 2021
Figure 19. Plasma-derived Factor VIII Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Plasma-derived Factor VIII Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Plasma-derived Factor VIII Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Plasma-derived Factor VIII Sales Market Share by Region (2017-2028)
Figure 23. Global Plasma-derived Factor VIII Revenue Market Share by Region (2017-2028)
Figure 24. North America Plasma-derived Factor VIII Revenue (2017-2028) & (USD Million)
Figure 25. Europe Plasma-derived Factor VIII Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Plasma-derived Factor VIII Revenue (2017-2028) & (USD Million)
Figure 27. South America Plasma-derived Factor VIII Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Plasma-derived Factor VIII Revenue (2017-2028) & (USD Million)
Figure 29. Global Plasma-derived Factor VIII Sales Market Share by Type (2017-2028)
Figure 30. Global Plasma-derived Factor VIII Revenue Market Share by Type (2017-2028)
Figure 31. Global Plasma-derived Factor VIII Price by Type (2017-2028) & (USD/Unit)
Figure 32. Global Plasma-derived Factor VIII Sales Market Share by Application (2017-2028)
Figure 33. Global Plasma-derived Factor VIII Revenue Market Share by Application (2017-2028)
Figure 34. Global Plasma-derived Factor VIII Price by Application (2017-2028) & (USD/Unit)
Figure 35. North America Plasma-derived Factor VIII Sales Market Share by Type (2017-2028)
Figure 36. North America Plasma-derived Factor VIII Sales Market Share by Application (2017-2028)
Figure 37. North America Plasma-derived Factor VIII Sales Market Share by Country (2017-2028)
Figure 38. North America Plasma-derived Factor VIII Revenue Market Share by Country (2017-2028)
Figure 39. United States Plasma-derived Factor VIII Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Plasma-derived Factor VIII Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Plasma-derived Factor VIII Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Plasma-derived Factor VIII Sales Market Share by Type (2017-2028)
Figure 43. Europe Plasma-derived Factor VIII Sales Market Share by Application (2017-2028)
Figure 44. Europe Plasma-derived Factor VIII Sales Market Share by Country (2017-2028)
Figure 45. Europe Plasma-derived Factor VIII Revenue Market Share by Country (2017-2028)
Figure 46. Germany Plasma-derived Factor VIII Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Plasma-derived Factor VIII Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Plasma-derived Factor VIII Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Plasma-derived Factor VIII Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Plasma-derived Factor VIII Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Plasma-derived Factor VIII Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Plasma-derived Factor VIII Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Plasma-derived Factor VIII Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Plasma-derived Factor VIII Revenue Market Share by Region (2017-2028)
Figure 55. China Plasma-derived Factor VIII Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Plasma-derived Factor VIII Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Plasma-derived Factor VIII Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Plasma-derived Factor VIII Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Plasma-derived Factor VIII Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Plasma-derived Factor VIII Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Plasma-derived Factor VIII Sales Market Share by Type (2017-2028)
Figure 62. South America Plasma-derived Factor VIII Sales Market Share by Application (2017-2028)
Figure 63. South America Plasma-derived Factor VIII Sales Market Share by Country (2017-2028)
Figure 64. South America Plasma-derived Factor VIII Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Plasma-derived Factor VIII Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Plasma-derived Factor VIII Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Plasma-derived Factor VIII Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Plasma-derived Factor VIII Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Plasma-derived Factor VIII Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Plasma-derived Factor VIII Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Plasma-derived Factor VIII Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Plasma-derived Factor VIII Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Plasma-derived Factor VIII Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Plasma-derived Factor VIII Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Plasma-derived Factor VIII in 2021
Figure 76. Manufacturing Process Analysis of Plasma-derived Factor VIII
Figure 77. Plasma-derived Factor VIII Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • イロクテイトの世界市場2022：200IU、250IU
  • 後天性血友病A治療薬のグローバル市場展望 2023年-2029年：200IU、250IU
  • 血漿分画のグローバル市場予測（～2028）：免疫グロブリン、アルブミン、プロテアーゼ阻害剤、フォンウィルブランド因子、PCC
  • 血漿由来製剤の世界市場 2023年-2027年
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22DC3895 )"血漿由来第VIII因子の世界市場2022：200IU、250IU" (英文：Global Plasma-derived Factor VIII Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。